LADENBURG THALMANN FINANCIAL SERVICES INC. - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 206 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$15,000
+50.0%
324
+4.5%
0.00%
Q3 2019$10,000
-33.3%
3100.0%0.00%
Q2 2019$15,000
-34.8%
310
-7.2%
0.00%
Q1 2019$23,000
+53.3%
334
+2.8%
0.00%
Q4 2018$15,000
+1400.0%
325
+3150.0%
0.00%
Q3 2018$1,000
-88.9%
10
-93.3%
0.00%
Q1 2017$9,000
+80.0%
150
+18.1%
0.00%
Q2 2016$5,000
-54.5%
127
-53.3%
0.00%
Q1 2016$11,000
-15.4%
272
+34.7%
0.00%
Q4 2015$13,000
-7.1%
202
-1.5%
0.00%
Q3 2015$14,000
-39.1%
205
-2.8%
0.00%
Q2 2015$23,000
+15.0%
2110.0%0.00%
Q1 2015$20,000
+150.0%
211
+197.2%
0.00%
Q4 2014$8,000
+100.0%
710.0%0.00%
Q3 2014$4,000
+33.3%
710.0%0.00%
Q2 2014$3,000710.00%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Rock Springs Capital Management LP 3,057,869$86,477,0002.23%
Eagle Health Investments LP 329,713$9,324,0002.14%
Bellevue Group AG 4,058,792$114,783,0001.65%
SUVRETTA CAPITAL MANAGEMENT, LLC 959,214$27,127,0001.13%
ARMISTICE CAPITAL, LLC 1,924,000$54,411,0000.94%
Integral Health Asset Management, LLC 100,000$2,828,0000.55%
Monarch Partners Asset Management LLC 57,820$1,635,0000.49%
ArrowMark Colorado Holdings LLC 1,380,389$39,037,0000.48%
AlphaCentric Advisors LLC 15,000$424,0000.44%
PDT Partners, LLC 72,778$2,058,0000.31%
View complete list of AGIOS PHARMACEUTICALS INC shareholders